Skip to NavigationSkip to content

News

Medigene has announced that it has bolstered the existing partnership it has in place with US firm bluebird bio, originally signed in 2016,...
After posting its financials from 2017 and its guidance for the year to come, it’s clear to see why Takeda needed to inject some growth into the...
President Trump’s speech on Friday afternoon had been long-anticipated, ever since he was elected and then hammered the pharma industry with talk...
The FDA has awarded approval for what it says is its first drug for the treatment of multiple sclerosis (MS) in paediatric patients, giving the...
In our latest free webinar, listen to Dr William Richardson, Medical Advisor at NDA Group, speak on how to best implement the revised GVP module...
NICE, the UK’s drug watchdog for the NHS, has decided that Janssen’s Tremfya (guselkumab) should be used routinely through the health service in...
It’s been a week in which one of the largest pharmaceutical takeovers in history took place and yet it’s not the most talked about event of the week...
Roche has been rocked by a Phase 3 weak showing from its combination Tecentriq (atezolizumab) and Cotellic (cobimetinib) in people with heavily pre...
AstraZeneca’s Fasenra arrived later on the scene than GSK rival med, Nucala, and so it needed to quickly rack up indications to mount a serious...
This workshop, through plenary and parallel sessions, will focus on current challenging topics within the global pharmaceutical/biopharmaceutical...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches